Month: March 2024

2071 posts
Vacplus Toilet Bowl Cleaners Surpass 1.5 Million Sales Milestone in Just 2 Years: A Testament to Quality, Affordability, and Customer Loyalty

Vacplus Toilet Bowl Cleaners Surpass 1.5 Million Sales Milestone in Just 2 Years: A Testament to Quality, Affordability, and Customer Loyalty

LOS ANGELES, March 9, 2024 /PRNewswire/ — Today, Vacplus, a burgeoning household…
City Lights, Stylish Sights: Vooglam's Neon Collection Unveiled

City Lights, Stylish Sights: Vooglam's Neon Collection Unveiled

AUSTIN, Texas, March 9, 2024 /PRNewswire/ — At the forefront of eyewear…
Guangdong Provincial Delegation Open Group Activities to Domestic and Foreign Media

Guangdong Provincial Delegation Open Group Activities to Domestic and Foreign Media

GUANGDONG, China, March 8, 2024 /PRNewswire/ — On the morning of March…
EVERISE EXPANDS FOOTPRINT IN THE PHILIPPINES WITH NEWEST MICROSITE IN ISABELA, CAUAYAN CITY

EVERISE EXPANDS FOOTPRINT IN THE PHILIPPINES WITH NEWEST MICROSITE IN ISABELA, CAUAYAN CITY

Targeting to bring over 1,000 jobs to help transform the local economy.…
WiMi Is Researching Blockchain Optimized Data Storage Model Based on Extreme Learning Machine (ELM) Sharding

WiMi Is Researching Blockchain Optimized Data Storage Model Based on Extreme Learning Machine (ELM) Sharding

BEIJING, March 8, 2024 /PRNewswire/ — WiMi Hologram Cloud Inc. (NASDAQ: WIMI)…
Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075 for the Treatment of Obesity

Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075 for the Treatment of Obesity

CAMBRIDGE, Mass., March 8, 2024 /PRNewswire/ — Regor Therapeutics Group ("Regor"), a…
3D Printing Trailblazer ELEGOO Announces Initiative to Boost Women's Roles in STEM

3D Printing Trailblazer ELEGOO Announces Initiative to Boost Women's Roles in STEM

SHENZHEN, China, March 8, 2024 /PRNewswire/ — In celebration of International Women’s…
Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range

Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range

Highlights Clarity recently reported that in its diagnostic Phase 1/2 trial, COBRA, 64Cu-SAR-bisPSMA…